Cell and Gene Therapy for Autoimmune Disorders

18 Jan 2023
15:30
Modalities and Indications Track
SPONSORED BY
JURA Bio

3:30pm Chair Introduction

Arun Das, Chief Business Officer, Cabaletta Bio

 

3:35pm Presentation: TBA

Karen Walker, Chief Technical Officer, Kyverna Therapeutics

 

3:50pm Presentation: TBA

Cameron Gardner, Director of Research, Jura Bio

 

4:05pm Presentation: TBC

Speaker TBC

 

4:20pm Presentation: Gene and Cell Therapy: A Patient Perspective

Gwen Binder, President, Science & Technology, Cabaletta Bio

 

4:35pm Closing Panel with Q&A

With all session participants

Speakers

Arun Das
Chief Business Officer
Cabaletta Bio
Cameron Gardner
Director of Research
JURA Bio
Gwen Binder
President, Science & Techology
Cabaletta Bio
Karen Walker
Chief Technical Officer
Kyverna Therapeutics